It’s Settled: Pay-for-Delay Challenges Had a Big Week
On both sides of the Atlantic, brand-name drug companies have paid generics to delay entering the market. The week of June 17, 2013 will go down as potentially the most important week ever in the history of challenges to this...
Read More
